Minims Tetracainhydrochlorid Bausch + Lomb Ireland Limited (Tetracaine Hydrochloride)

Tetracaine Hydrochloride is used in ophthalmology to provide local anesthesia for various eye conditions.

• Diagnostic eye examinations: provides temporary numbness to allow thorough corneal and conjunctival assessment.
• Minor ocular surgery: facilitates painless performance of procedures such as foreign body removal or laser treatment.
• Eye irritation pain relief: reduces discomfort from chemical or mechanical irritants on the ocular surface.

• Tetracaine Hydrochloride exerts its effect by reversibly blocking voltage‑gated sodium channels on peripheral nerve membranes in the cornea and conjunctiva. This inhibition prevents the initiation and propagation of nerve impulses, thereby producing a rapid and localized loss of sensation without affecting deeper ocular structures. The drug diffuses across the epithelial layer, achieving effective concentrations within the superficial nerve endings, and its action is short‑lasting as the compound is metabolized by ocular esterases.

Topical ocular administration of tetracaine may be associated with a range of adverse reactions, varying from mild to serious.

Common Side Effects

• Burning sensation: transient stinging upon instillation.
• Redness: mild conjunctival hyperemia.
• Tearing: increased lacrimation.
• Blurred vision: temporary visual disturbance.
• Foreign body sensation: feeling of grit in the eye.
• Photophobia: light sensitivity for a short period.

Serious or Rare Side Effects

• Corneal epithelial toxicity: ulceration or delayed healing.
• Severe corneal edema: swelling that may impair vision.
• Allergic reaction: swelling, itching, or rash of the eyelid or surrounding skin.
• Vision loss: rare but possible if toxicity is severe.

When using Minims Tetracainhydrochlorid, clinicians should observe specific precautions to ensure patient safety and product integrity.

• Indication verification: confirm the need for ocular anesthesia before administration.
• Contraindication check: avoid use in patients with known hypersensitivity to tetracaine or other ester anesthetics.
• Duration limit: limit exposure to the recommended short period to reduce risk of corneal toxicity.
• Monitoring: observe the eye for signs of irritation, delayed healing, or allergic response after use.
• Store at room temperature: keep the container sealed, protect from light and moisture, and store below 25 °C.

Tetracaine may interact with certain ophthalmic agents, altering its efficacy or safety profile.

Major Interactions (Avoid)

• Anticholinesterase eye drops: can potentiate local anesthetic effect leading to prolonged numbness.
• Corneal healing agents (e.g., sodium hyaluronate): may be less effective if applied immediately after tetracaine.
• Beta‑blocker eye drops: may increase intra‑ocular pressure changes when combined.

Moderate Interactions (Monitor Closely)

• Topical antibiotics: concurrent use may increase risk of corneal toxicity; monitor ocular surface.
• Other ocular anesthetics: combined use can enhance neurotoxicity; adjust dosing and observe closely.
• Non‑steroidal anti‑inflammatory eye drops: may increase irritation risk.